Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
179.81
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Gilead Sciences Completes Acquisition of Kite Pharma, Inc.
October 03, 2017
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a wholly-owned subsidiary of Gilead (“Purchaser”), to acquire...
From
Business Wire News Releases
Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.
October 03, 2017
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers Merger Sub, Inc. (“Purchaser”), for all of the outstanding...
From
Business Wire News Releases
Performance
More News
Read More
Loncar Cancer Immunotherapy Index Announces Merger Replacements
October 04, 2017
From
Business Wire News Releases
Gilead Sciences Outlook Brightens; Citi Upgrades
January 30, 2018
Tags
Robyn Karnauskas
Benzinga
Analyst Ratings
From
Benzinga
Daily Technical Summary Reports on Biotech Stocks -- Gilead Sciences, Kite Pharma, Novavax, and Sangamo Therapeutics
September 28, 2017
From
PR Newswire
ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More
December 13, 2017
Tags
Top Stories
NVS
Analyst Ratings
From
Benzinga
Maxim Explains Why Gilead Sciences Is A Now A Buy
November 30, 2017
Tags
Upgrades
General
Jason McCarthy
From
Benzinga
As Gilead's Outlook Dims, Argus Downgrades
November 13, 2017
Tags
Health Care
GILD
Argus
From
Benzinga
Ford Model T And Personalized Medicine
December 11, 2017
Tags
Stocks / Equities
Healthcare
Pharma/Biotech
From
Blogs - TalkMarkets
Life (Science) Lessons: The Hows And Whos To Play Biotech
October 06, 2017
Tags
Top Stories
Interview
Trading Ideas
From
Benzinga
3 Healthcare Value Stocks
October 24, 2017
Tags
KITE
MASI
GILD
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.